Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Tarsus Pharmaceuticals, Inc.

Balance Sheet

Standardized | As Reported Annual | Quarterly
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   8-K10-K10-K10-KS-1/A
ASSETS       
Current assets:       
    Cash and cash equivalents       
    Marketable securities   0.5   
    Other receivables  3.60.10.00.0 
    Prepaid expenses  4.8  0.0 
        Total current assets  225.4176.0170.758.0 
Property and equipment, net  1.00.80.50.2 
Operating lease right-of-use assets   1.10.7  
Other assets  0.61.10.10.0 
    Total assets  227.9178.9172.058.3 
   
LIABILITIES AND STOCKHOLDERS' EQUITY       
Current liabilities:       
    Accounts payable and other accrued liabilities   8.74.30.5 
    Accrued payroll and benefits  5.52.81.00.3 
        Total current liabilities  15.411.55.40.8 
Other long-term liabilities  0.10.70.60.1 
    Total liabilities  35.012.26.00.9 
   
Commitments and contingencies (Note 8)       
Stockholders’ equity:       
    Common stock  0.00.00.00.0 
    Additional paid-in capital  301.7213.4198.80.0 
    Accumulated other comprehensive loss  -0.1    
    Accumulated deficit  -108.8-46.7-32.8-6.0 
        Total stockholders’ equity  192.9166.7166.0-6.0 
    Total liabilities and stockholders’ equity  227.9178.9172.058.3 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy